Independent pharmacies across the United States are under mounting financial strain, with a significant portion of owners now weighing whether to shut their businesses entirely. A recent National Community Pharmacists Association survey
More
The US Court of Appeals for the DC Circuit denied consolidated industry petitions challenging the Environmental Protection Agency’s 2024 designation of PFOA and PFOS as hazardous substances. The ruling, handed down on
More
Ulta Beauty faces mounting legal pressure after a court determined its privacy policy alone cannot constitute valid consent under the California Invasion of Privacy Act. The ruling stems from the class action
More
Andrew Haden, a longtime federal prosecutor who twice served as acting U.S. attorney, has died at the age of 48 in California. Haden was discovered dead last week inside a vacant office
More
Lawyers representing Luigi Mangione are arguing their client cannot face murder charges in New York following his guilty plea to federal stalking offences. At the heart of the legal argument is a
More
The FTSE 100 has climbed back above 10,800 points and is closing in on fresh record highs after a strong run. The index has gained 16.8% over the past year, driven by
More
Berkshire Hathaway has shifted back into net buyer territory in equities markets, marking a notable change in the conglomerate’s recent investment posture. The company, led by legendary investor Warren Buffett, had spent
More
The US Treasury is considering using its near $1 trillion General Account to fund an expanded programme of government bond purchases, according to two senior Treasury officials. Treasury Secretary Scott Bessent has
More
Burnham Faces Backlash Over ‘Piecemeal’ Business Rates Review That Ignores Retailers And Restaurants
Andy Burnham has been accused of failing to honour Labour’s manifesto pledge to overhaul the business rates system, opting instead for a narrow review targeting pubs and hotels. The Treasury launched the
More
Daiichi Sankyo is promoting Ken Keller to lead a newly created globally integrated commercialization unit as part of its ambition to become a top five oncology company by 2035. The Japanese drugmaker
More